KINAXO Biotechnologies
Martinsried
About KINAXO Biotechnologies
KINAXO Biotechnologies is a privately-held biotechnology company based in Munich/Martinsried, Germany. They are a service company specializing in chemical proteomics methods to support the successful development of small molecule drugs. As a spin-off of the Max Planck Institute of Biochemistry in Martinsried, they continuously expand and improve their technology platform in collaboration with the leading Max Planck laboratories of Axel Ullrich, Henrik Daub and Matthias Mann. KINAXO offers its clients extensive experience in cellular target profiling and other chemical proteomics applications.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Funding stage: M&A
- Last round: Series A (May 2007)
- Website: kinaxo.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/kinaxo-biotechnologies-2187730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.